David Liposarcoma Research Initiative
Liposarcomas originate from precursors of fat cells are one of 250 types of sarcoma and are relatively rare, but they have few effective treatments. The David Liposarcoma Research Collaboration is led by DFCI Investigator George Demetri and aims to transform the treatment of this rare, underfunded, and understudied disease. As part of this effort, the LSP is collecting highly multiplexed images of liposarcomas before and after treatment.
- George Demetri, MD, Professor of Medicine, Harvard Medical School
- Sandro Santagata, MD PhD, Associate Professor of Pathology, Brigham and Women’s Hospital and Harvard Medical School
- Peter Sorger, PhD, Professor of Systems Biology, Harvard Medical School